Skip to main content

Table 2 Three-year overall and relapse-free survival rates, and one-year survival after relapse rates in MSS/left and MSS/right populations, stratified by mutation status

From: Context-dependent interpretation of the prognostic value of BRAF and KRAS mutations in colorectal cancer

  MSS/left MSS/right
Population Survival rate 95% CI Survival rate 95% CI
OS: 3-year survival rates
WT2 0.91 0.88-0.93 0.83 0.77-0.89
KRAS mut 0.89 0.85-0.93 0.80 0.74-0.86
BRAF mut 0.37 0.20-0.66 0.73 0.60-0.89
RFS: 3-year survival rates
WT2 0.75 0.71-0.80 0.75 0.68-0.82
KRAS mut 0.68 0.62-0.74 0.73 0.66-0.80
BRAF mut 0.32 0.16-0.61 0.68 0.54-0.84
SAR: 1-year survival rates
WT2 0.81 0.74-0.88 0.65 0.52-0.82
KRAS mut 0.80 0.71-0.89 0.75 0.53-0.80
BRAF mut 0.17 0.05-0.60 0.36 0.17-0.79